Journal Article

Evaluation of the Therapeutic Effect of Curcumin-Conjugated Zinc Oxide Nanoparticles on Reserpine-Induced Depression in Wistar Rats

Mohamed, Ayman S., Fahmy, Heba M., Khadrawy, Yasser A., Aboalasaad, Fatmaalzahraa A., Elhusseiny, Fathi A., Elmekawy, Ahmed

2024

Overview

Depression, a devastating brain illness, necessitates the exploration of novel antidepressant treatments. We evaluated the antidepressant effects of free curcumin, zinc oxide nanoparticles (ZnO NPs), and curcumin-conjugated zinc oxide nanoparticles (Zn(cur)O NPs). The nanoformulations were extensively characterized using advanced techniques. An acute toxicity study ensured the safety of Zn(cur)O NPs. Rats were assigned to one of five groups: control, reserpine-induced depression model, treatment with ZnO NPs, free curcumin, or Zn(cur)O NPs. Behavioral assessments (forced swimming test [FST] and open-field test [OFT]) and neurochemical analyses were conducted. Zn(cur)O NPs exhibited superior efficacy in ameliorating reserpine-induced behavioral and neurochemical effects compared to free curcumin and ZnO NPs. The reserpine-induced model displayed reduced motor activity, swimming time, and increased immobility time in the FST and OFT. Treatment with Zn(cur)O NPs 45 mg/kg significantly improved motor activity and reduced immobility time. Furthermore, Zn(cur)O NPs decreased malondialdehyde (MDA) levels while increasing reduced glutathione (GSH) and catalase (CAT) levels. Additionally, concentrations of serotonin (5-HT) and norepinephrine (NE) increased. In conclusion, curcumin-conjugated zinc oxide nanoparticles demonstrate potent antidepressant effects, alleviating depressive-like behavior in rats. These findings support Zn(cur)O NPs as a promising therapeutic strategy for depression management, warranting further investigation and clinical validation.

• Publisher: Springer US,Springer Nature B.V
• Subject: Acute toxicity / Animal models / Animals / Antidepressants / Antidepressive Agents - chemistry / Antidepressive Agents - pharmacology / Behavior, Animal - drug effects / Biochemistry / Biomedical and Life Sciences / Biotechnology / brain / Catalase / Curcumin / Curcumin - chemistry / Curcumin - pharmacology / Depression - chemically induced / Depression - drug therapy / Disease Models, Animal / Engines / Field tests / Glutathione / Life Sciences / Male / Malondialdehyde / Mental depression / Motor activity / Nanoparticles / Nanoparticles - chemistry / Norepinephrine / Nutrition / Oncology / Open-field behavior / Rats / Rats, Wistar / Reserpine / Reserpine - pharmacology / Serotonin / Swimming / Swimming behavior / therapeutics / Toxicity / Zinc / Zinc oxide / Zinc Oxide - chemistry / Zinc Oxide - pharmacology / Zinc oxides